Unraveling the complexity of the ATMP transition from a research-grade to a clinical-grade product

Speaker: Ion Tcacencu –  is an ATMP expert with over 17 years of experience as scientist within regenerative medicine and immunology, being responsible for projects developing new ATMPs.

Ready to explore the cutting-edge world of Advanced Therapy Medicinal Products (ATMPs)?

Don’t miss this exclusive webinar where we delve into the intricacies of ATMPs development and manufacturing! 

Sign up now for an insightful agenda featuring key topics:

Agenda:

  1. General aspects of the ATMPs development.
  2. Overview of the Quality Target Product Profile (QTPP) and critical quality attributes (CQAs). ​

hVIVO plc (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and long-standing client base of biopharma companies.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    hVIVO plc

    More articles like this

    hVIVO plc

    hVIVO fast-tracks drug trials and draws big pharma in

    In a sector where timelines can stretch over decades and budgets run into billions, hVIVO is rewriting the rules—delivering clinical insight in a fraction of the time and attracting heavyweight pharmaceutical partners along the way. hVIVO